Healthy scents: microbial volatiles as new frontier in antibiotic research? by Avalos, Garcia M. et al.
1Healthy scents: microbial volatiles as new frontier in antibiotic research?
Mariana Avalos1, Gilles P. van Wezel1,2, Jos M. Raaijmakers1,2, Paolina Garbeva2*.
1Institute of Biology, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands. 
2Netherlands Institute of Ecology, Droevendaalsesteeg 10, 6708 PB Wageningen, The 
Netherlands.
* Corresponding author: p.garbeva@nioo.knaw.nl
 
2ABSTRACT
Microorganisms represent a large and still resourceful pool for the discovery of novel 
compounds to combat antibiotic resistance in human and animal pathogens. The ability of 
microorganisms to produce structurally diverse volatile compounds has been known for 
decades, yet their biological functions and antimicrobial activities have only recently attracted 
attention. Various studies revealed that microbial volatiles can act as infochemicals in long-
distance cross-kingdom communication as well as antimicrobials in competition and 
predation. Here, we review recent insights into the natural functions and modes of action of 
microbial volatiles and discuss their potential as a new class of antimicrobials and modulators 
of antibiotic resistance. 
INTRODUCTION
The problem of antimicrobial resistance
The discovery and use of antibiotics to treat infectious diseases has dramatically affected 
human life spans. Nevertheless, the increasing use of antibiotics has led  to a rapid acquisition 
of antibiotic resistance by pathogenic microorganisms [1,2] as was already predicted by 
Alexander Fleming shortly after he discovered penicillin [3]. The threat of the increased 
frequency of antibiotic resistance is further augmented by the reduced interest and efforts of 
the pharmaceutical industry to discover and develop novel antibiotics [4-6]. Therefore, 
scientists are taking the lead in finding new strategies to identify new antibiotics to turn the 
tide of antibiotic-resistance[7]. In particular, we need to expand the chemical space of 
bioactive molecules with different modes of action and for which resistance development is 
less likely to occur. To date, the attention of industrial screening efforts has been almost 
exclusively directed at canonical antibiotic classes such as polyketides (PKS), nonribosomal 
3(NRPS) and ribosomal (RiPP) peptide antibiotics, β-lactams and aminoglycosides. However, 
there is a major and highly diverse class of natural products that has been largely ignored by 
the pharmaceutical industry, namely the volatile compounds. Research on microbial volatiles 
is an emerging field with immense potential for both human, animal and plant health [8-11]. 
Here, we provide a brief and up-to-date overview of recent studies concerning the natural 
functions of microbial volatiles with a specific focus on volatiles that have antimicrobial 
activity or that act as modulators of antimicrobial resistance.  
Chemical diversity and natural functions of microbial volatile compounds (MVCs)
Bacteria and fungi release a plethora of organic and inorganic volatile compounds, small 
molecules with low molecular weight and high vapour pressure. These physicochemical 
properties enable MVCs to diffuse more easily, allowing dispersal over longer distances than 
other microbial metabolites. A decade ago, the excellent review by Schulz and Dickschat [12] 
on microbial volatiles marked the rise of this emerging and exciting research field of natural 
product chemistry. Since then, numerous structurally diverse MVCs produced by marine and 
terrestrial microorganisms have been described [13,14].  MVCs belong to diverse chemical 
classes, including alkanes, alkenes, alcohols, esters, ketones, terpenoids, sulfur-containing 
compounds and a range of small inorganic compounds. Moreover, within these classes there 
appears to be an enormous chemical diversity of MVCs that remains to be discovered as 
exemplified by the terpenes sodorifen [15] and pristinol [16]. MVCs may be unique to a single 
phylogenetic group or even species, which also allows the use of MVCs for chemotaxonomic 
purposes [17] and for the selective detection of pathogens in both indoor and outdoor 
environments [18]. For example, VCs produced by M. tuberculosis help to detect the 
pulmonary infection and asses the efficacy of treatment [19]. 
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Activities reported for MVCs include modulation of growth, motility, virulence and biofilm 
formation as well as production of specialized metabolites (e.g. toxins), antibiotic resistance 
and spore germination in competing microorganisms (i.e. bacteria, fungi) [22-27]. For 
example, some Streptomyces species surpass obstacles by so-called ‘explorer cells’, whereby 
they colonize new areas in the face of competition induced by the biogenic volatile 
trimethylamine [28]. The skin-borne Staphyloccoccus schleiferi produces schleiferons A and B 
that modulate the skin microbiome possibly by inhibiting the growth of Gram-positive bacteria 
and by interfering with prodiginines production [26]. Plants also respond to and utilize MVCs 
leading to growth promotion or inhibition, induced systemic resistance or alteration of the 
plant metabolome [11,29,30]. Recent studies further point to other intriguing ecological roles 
of MVCs in cross-kingdom interactions. For example, ammonia produced by bacteria 
promotes the symbiosis between a fungus and a beetle by regulating the consumption 
sequence of the carbon sources pinitol and glucose [31]. Other studies indicated that volatiles 
from Bacillus subtilis Pseudomonas fluorescens, Serratia odorifera, and Xanthomonas 
campestris act as infochemicals disclosing a food source to bacterial predators, whereby the 
nematode Caenorhabditis elegans responded by crossing a 3-cm plastic barrier presumably to 
feed on the bacteria [9].  In contrast,  MVCs like acetaldehyde, cyclohexene and dimethyl 
disulfide, were reported to reduce the motility of nematodes [32]. Recent studies in our labs 
further revealed that terpenes from Collimonas may act as a defense mechanism against 
protozoan predation [21]. Also the terpene geosmin produced by Streptomyces and other 
bacteria has been proposed to be multifunctional as a signaling molecule involved in 
sporulation of the producing strain [33] and as a deterrent in food for Drosophila flies [34]. For 
more comprehensive overviews of other natural roles of MVCs in intra- and interspecific 
5interactions and cross-kingdom communication, we refer to several recent reviews [9,14,35-
39]. 
Microbial volatile compounds as antimicrobials
MVCs can have significant inhibitory effects on the growth or development of other 
microorganisms (Figure 2). The activity spectrum of MVCs appears to be as diverse as their 
chemistry. Most of the studies to date have focused on antifungal activities of MVCs and only 
a few have reported their antibacterial properties. Examples include: the hormone-like γ-
butyrolactones with broad spectrum activity against bacteria, fungi and yeast [13]; furfuryl 
isovalerate that inhibits growth of Gram-positive and Gram-negative bacteria, and acts as a 
quorum quencher in Gram-negative bacteria [13]; pyrazines (2,5-bis (1-methylethyl)-
pyrazine), produced by Paenibacillus in interaction with Burkholderia [40], with activity against 
human pathogenic bacteria like Escherichia. coli, Staphylococcus aureus and the yeast Candida 
albicans. Interestingly, only few studies to date have looked into the antibacterial activities of 
MVCs produced by actinobacteria (Figure 2), the most prolific producers of known antibiotics, 
anticancer, antifungal, immunosuppressant and herbicidal compounds [41,42]. Preliminary 
experiments conducted in our labs suggest that the role of actinobacterial MVCs as antibiotics 
has been grossly underestimated. Our experiments indicated that approximately 15% of all 
actinobacteria species tested (N=200) can inhibit the growth of Bacillus subtilis or Escherichia 
coli in an experimental setup where the actinobacteria were physically separated from the 
target (Avalos et al. unpublished data). Intriguingly, those actinobacterial strains that produce 
volatiles that inhibit the growth of the Gram-positive B. subtilis did not inhibit growth of the 
Gram-negative E.coli and vice versa, suggesting that actinobacterial MVCs exhibit different 
modes of action.
6The antimicrobial activity of MVCs can be further enhanced via synergy with ‘soluble’ 
antibiotics. For example, pre-treating antibiotic-resistant bacteria with the terpene eugenol 
lowered the minimal inhibitory concentration (MIC) such that they became antibiotic sensitive 
again [43]. Similarly, phenylpropanoids such as β- cinnamic and ferulic acid, conferred 
sensitivity to amikazin, erythromycin and vancomycin [43]. A mixture of the monoterpenes γ-
terpinene, 1S-α-pinene, β-pinene and β-myrcene produced by Collimonas  pratensis inhibited 
growth of  S. aureus and E. coli [44]. Additionally, essential oil components such as limonene, 
sabinene, α-pinene, thymol and carvacrol have been shown to have potential as enhancers of 
anti-tuberculosis drugs like ethambutol, rifampicin and isoniazid [45].
Modes of action of MVCs
Despite the observations that many MVCs have antimicrobial activity, only few studies 
provided insight into their modes of action. Pentalenolactone is an example with a specific 
intracellular target; it impedes glycolysis by inhibiting glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) [46]. Another example comes from Muscodor albus, a fungus that 
produces an antimicrobial blend of volatiles [47] that appears to operate by causing DNA 
damage; E. coli cells became particularly sensitive to these MVCs when they lack the enzymes 
(e.g. RecA) for DNA repair [48]. Another mode of action proposed is the modification of 
membrane fluidity/permeability by MVCs, allowing their entry into the cell or causing 
increased leakage of intracellular materials [49]. This mode of action might be widespread 
among MVCs from different microbial families. For example, VCs from yeasts such as 3-
methyl-1-butanol disrupt the fungal membrane by increasing the peroxidation levels of 
membrane lipids, thereby causing a non-selective permeability of the plasma membrane [50]. 
Other modes of action comprise the interference of MVCs with cell-to-cell communication or 
7quorum sensing. The aforementioned schleiferon A and B inhibit quorum sensing, thereby 
reducing the expression of prodigiosin and bioluminescence in Gram-negative bacteria [26]. 
Another well-studied example is the diffusible signal factor DSF (cis-11-methyl-2-dodecenoic 
acid) which modulates the virulence factors in Xanthomonas campestris [51,52]. In B. subtilis,  
DSF-family signals significantly decreased the transcription of drug efflux systems and biofilm 
formation [53]. Homologs occur in many bacteria. One example is Stenotrophomonas 
maltophilia, a Gram-negative bacterium that is found ubiquitously in different environments, 
including nosocomial infections where it affects biofilm formation in Pseudomonas 
aeruginosa, a lung pathogen associated with cystic fibrosis [54,55]. 
MVCs as modulators of antibiotic resistance
An important activity of MVCs in the light of this review is their ability to modulate antibiotic 
resistance. Recently, Groenhagen et al. [56] demonstrated that the volatiles 1-methylthio-3-
pentanone and o-aminoacetophenone from Burkholderia ambifaria increased resistance of 
E. coli to aminoglycoside antibiotics like gentamicin and kanamycin. Trimethylamine (TMA) 
modified resistance to tetracycline by increasing the pH and lowering the transport of 
tetracycline inside the cell due to changes in transmembrane pH and proton motive force 
[57]. Slow-growing cells present in a normal growing population, also referred to as persister 
cells or persisters, evolve tolerance to antibiotics and other environmental stresses. 
Recently, a link was established between persistence and a toxin-antitoxin system. High 
persistence (hip) mutants exhibited significant survival after treatment with cell wall 
inhibitors. The mutations were mapped to a toxin-antitoxin locus (hipBA).  In this example, 
the toxin HipA inactivates glutamyl-tRNA synthetase by phosphorylation, thereby inhibiting 
cell growth [58,59]. The anti-toxin HipB is a transcriptional repressor that neutralizes HipA 
8and regulates hipBA expression [60,61]. Microarray data of E. coli exposed to VCs emitted by 
B. subtilis showed induction of the expression of hipA and hipB, thereby inducing resistance 
[24,62]. Specifically, 2, 3-butanedione and glyoxylic acid produced by B. subtilis enhance 
resistance to ampicillin and tetracycline in E. coli through hipBA [24]. 2-Aminoacetophenone 
(2-AA) produced by P. aeruginosa regulates quorum sensing and also stimulates persister 
cell formation. The long-range effect of this volatile also influenced persister cell formation 
in pathogenic bacteria belonging to a different genus that do not produce 2-AA, like 
Acinetobacter baumanii [25]. Interestingly, microorganisms may also 'eavesdrop' the 
signalling molecules produced by other microorganisms, thereby taking advantage of their 
effect. As an example, Pseudomonas putida recognizes indole produced by E. coli, which 
induced the Pseudomonas TtgGHI antibiotic efflux pump allowing its growth in the presence 
of ampicillin [63].
Besides organic  MVCs, it is becoming clear that  small inorganic MVCs (such as 
hydrogen cyanide (HCN)) can have a major effect on antibiotic resistance. We propose that 
this is a general phenomenon and to exemplify our proposition we discuss three molecules 
here, hydrogen sulphide (H2S), nitric oxide (NO) and ammonia (NH3).  H2S and NO have 
overlapping activities and play an important role in the protection against oxidative stress 
and against antibiotics. Interference with H2S production by Bacillus anthracis, P. aeruginosa, 
S. aureus, and E. coli rendered these human pathogenic bacteria sensitive to a range of 
different antibiotics, which could be reversed to resistance by adding exogenous H2S [64]. 
Interestingly, H2S provided protection against many classes of antibiotics targeting DNA, 
RNA, cell wall or protein biosynthesis[64]. These modulating activities have also been 
attributed to nitric oxide (NO), mainly  due to the pioneering work of Gusarov and Nudler 
[65-68]. NO is produced from arginine by nitric oxide synthases (bNOS) that are present in 
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bacteria such as Bacillus anthracis against oxidative stress and survival in macrophages 
[65,67]. However, NO also directly protected bacteria against a broad spectrum of antibiotics 
[66,68]. In nature, this trait likely evolved to allow NO-producers to share their habitat with 
other antibiotic-producing species [66]. B. subtilis cells producing NO are able to grow in the 
presence of P. aeruginosa producing the toxin PYO [66]. Similarly, B. subtilis and S. aureus 
grow in the presence of cefuroxime only when producing NO, while nos null-mutants cannot 
[66]. NO-mediated resistance is achieved through direct chemical modification of toxic 
compounds [66]. The role of NO may even go a lot further, as it was shown that the lifespan 
of the NO non-producing C. elegans is expanded significantly when it feeds on NO-producing 
bacilli, offering a striking new example of symbiosis mediated by a volatile compound [69].
Ammonia (NH3) generated by the catabolism of aspartate, promotes intracellular 
accumulation of polyamines modifying E. coli membrane permeability thereby increasing 
resistance to tetracycline [70]. In contrast, exposure to ammonia decreased resistance to 
kanamycin. This effect could be explained by a higher expression of the polyamine-induced 
protein OppA, a periplasmic binding protein involved in uptake of aminoglucosides [71]. We 
have recently established that E. coli cells become more resistant to NH3 by reducing the 
expression of the regulatory system (ompR/envZ) of the major outer membrane porins 
OmpF & OmpC. These results suggest that porins represent a major point of entry for 
ammonia (Avalos et al., unpublished data). 
Outlook and perspectives
Microorganisms are rich sources of VCs. However, their functions and role as antimicrobial are 
yet poorly understood. Some MVCs are produced by many different bacterial genera, while 
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others are unique at the species level providing useful information for microbial 
chemotaxonomy and detection. Furthermore, some MVCs are only induced during 
interspecific interactions, suggesting a major role in communication and/or competition. 
For most bioactive MVCs the genes involved in biosynthesis and regulation are yet 
unknown. There is indication that the production of some ‘soluble’ and volatile compounds is 
encoded by the same genes, for example blastmycinones and butenolides are derived from 
the antimycin biosynthetic pathway [72]. Salinisporamide A, an anticancer compound 
presently undergoing clinical trials is synthesized using previously unknown volatile 
cyclohexene derivatives as intermediates [73].  Such evidence calls for integrative 
bioinformatics and systems biology approaches to unravel their biosynthesis and study 
synergism between soluble and volatile compounds. This should shed more light on how 
closely related these seemingly different ‘worlds’ of natural products are. 
Examples reviewed here bring attention to the fact that MVCs can serve as a self-defence 
mechanism for the producer or the community. We firmly believe that the near complete 
omission of volatile compounds from drug discovery efforts needs to be reconsidered 
especially at a time where new antibiotic treatments are so desperately needed to counteract 
antimicrobial resistance. One argument that is often heard is that volatile compounds need to 
be solubilized before they can be applied. This may be true for topical or IV application, but 
we would like to point out that some of the diseases that are most difficult to treat such as 
the lung diseases tuberculosis and cystic fibrosis may be targeted by MVCs . Inhaling MVCs 
should be considered as a possible therapy in addition to regular antibiotic regimes, taking 
advantage of their direct and modulating effects described in this review. The information 
gathered can also be used in the design and development of novel chemical structures and 
therapies such as the example given by Abed, N. et al., (2015) [74], where they use the natural 
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terpenes farnesyl and geranyl to design a nano-device that takes advantage of the formation 
of an environmentally sensitive bond between the terpenes and penicillin helping the delivery 
of the antibiotics directly into cells.
 ‘Small-talk’ molecules like the terpene 3-carene produced under poor-nutrient growth 
conditions [27] or the pyrazines produced by Paenibacillus during its interaction with 
Burkholderia  [40] play an important role as infochemicals as they are produced specifically 
when needed while the smaller inorganic  molecules like NH3 or NO produced in high amounts 
make a ‘loud noise’ that is easily perceived by different organisms.   
Improving our understanding of the natural roles of volatile compounds in the 
microbial environment (i.e. learning from nature) would greatly help in the search for novel 
bioactive molecules for drug development or as biomarkers for clinical and industrial 
purposes.
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Figure 1. Examples of MVCs with antimicrobial activity
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Figure 2. Chemical classes of volatile compounds released by bacteria. Highlighted in purple are the VCs
identified in Streptomyces strains. Zoomed compounds in green correspond to the widespread terpene
geosmin (non-active as antibiotic) and ammonia (active as antimicrobial). At the center two-compartment
plates: (1) Streptomyces strain (left L) producing high amount of ammonia inhibiting the growth of E. coli (right
R) and (2) Streptomyces strain (left L) producing geosmin not inhibiting the growth of E. coli (right R)
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Figure 3. MVCs  modes of action as antimicrobials and modulators of antibiotic resistance.
